Bill Title: Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agents approved by the federal food and drug administration.

Spectrum: Bipartisan Bill

Status: (Introduced) 2024-06-03 - PRINT NUMBER 8991A [S08991 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Amended	2024-04-08	HTML/Text	Link	View
Introduced	2024-04-08	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for New York S08991

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for New York S08991 currently on file.

Social Comments on NY S08991